No Data
No Data
Lumos Diagnostics CEO Doug Ward Announces Expanded Distribution for FebriDx and New Market Entries | ASX:LDX, OTC:LDXHF
Lumos Diagnostics Expands Distribution Deal With Henry Schein for Respiratory Infection Test
Lumos Diagnostics (ASX:LDX) extended its agreement with Henry Schein Medical's European business for the FebriDx acute respiratory infection test, expanding its distribution to include Belgium, accord
Lumos Diagnostics Expands Distribution Deal With Regional Health Care Group for Respiratory Infection Test
Lumos Diagnostics (ASX:LDX) and Regional Health Care Group expanded their distribution partnership for the FebriDx acute respiratory infection test to include Australia and New Zealand, according to a
Lumos Diagnostics Receives $400,000 in Milestone Payment From Hologic; Shares Up 3%
Lumos Diagnostics Holdings (ASX:LDX) received $400,000 in milestone payment from women's health company Hologic as part of a development agreement announced in January, according to a Wednesday filing
Lumos Diagnostics Secures Additional US$5m for Pioneering Pre-term Birth Test Development
Lumos Diagnostics (ASX: LDX) has received a second US$5 million payment from women’s health firm Hologic Inc under an intellectual property (IP) agreement signed between the two companies in January.
Lumos Diagnostics Receives Second Payment Under IP Agreement; Shares Up 8%
Lumos Diagnostics (ASX:LDX) received the second payment of $5.0 million from Hologic under an intellectual property agreement disclosed in January. This brought the total payments received under the a
No Data